Boston Scientific Corp. (BSX)

32.96
NYSE : Health Technology
Prev Close 32.51
Day Low/High 32.35 / 32.98
52 Wk Low/High 24.54 / 37.30
Avg Volume 7.75M
Exchange NYSE
Shares Outstanding 1.38B
Market Cap 44.86B
EPS 0.10
P/E Ratio 406.38
Div & Yield N.A. (N.A)

Latest News

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Jim Cramer and our other experts discuss the AT&T/Time Warner ruling, Alzheimer plays, and day traders risk.

Stryker Says Not in Talks to Buy Boston Scientific

Stryker Says Not in Talks to Buy Boston Scientific

The medical device firm issues an 8-K filing on the heels of a media report earlier this week that said it recently made a takeover approach to Boston Scientific.

Stocks Rise Cautiously Ahead of Trump-Kim Meeting

Stocks Rise Cautiously Ahead of Trump-Kim Meeting

Stocks closed higher on Monday as Wall Street prepares for an extraordinary week for risk events around the world.

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

The major U.S. averages closed the day in the green Monday.

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Jim Cramer and our other experts discuss Trump and stocks, trade, and pajama trading.

Boston Scientific Jumps on Report of Stryker Takeover Approach

Boston Scientific Jumps on Report of Stryker Takeover Approach

The Wall Street Journal reports Stryker made a takeover approach for the medical device company.

Boston Scientific Announces Scheduled Presentations At Digestive Disease Week 2018

Boston Scientific Announces Scheduled Presentations At Digestive Disease Week 2018

MARLBOROUGH, Mass., June 1, 2018 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced key data that will be presented at Digestive Disease Week (DDW) being held in Washington D.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AMCX, APAM, BEAT, BSX, CIO, CRZO, EFII, FNB, LNDC, NTWK, OXSQ, SIR, VOC, WHG Downgrades: ABEV, ARNC, BMS, EMCI, ERII, ESGR, ESLT, GASS, IVZ, LPL, PICO Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Medical Device Stocks Could Be Gearing Up to Be Market Leaders

Medical Device Stocks Could Be Gearing Up to Be Market Leaders

When chartists look for the next market leaders they often go to stocks that have held up the best during corrections.

Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back

Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back

The crash of oil will only accelerate the move.

Jana Partners Takes Positions in Adobe, Apple, Anthem, AutoDesk, Others

Jana Partners Takes Positions in Adobe, Apple, Anthem, AutoDesk, Others

The insurgent manager who helped engineer the Amazon-Whole Foods combination opened a window into his latest allocations, any of which could become campaigns. Here's a wrap up of his investments as well as new developments from Mick McGuire's Marcato Capital and Dan Loeb's Third Point.

Boston Scientific Announces Real-World Data Demonstrating Success Of SMART Pass On The S-ICD System

Late-Breaker Data Highlight Reduction in Rate of Inappropriate Shocks with Sensing Filter

Boston Scientific Announces Acquisition Of Securus Medical Group, Inc.

Boston Scientific Announces Acquisition Of Securus Medical Group, Inc.

Acquisition strengthens electrophysiology cardiac ablation portfolio with thermal monitor

Boston Scientific Prevails In U.K. Edwards Lifesciences Litigation

Boston Scientific Prevails In U.K. Edwards Lifesciences Litigation

U.K. Court Affirms that Edwards Lifesciences Infringes Boston Scientific Patent

Boston Scientific Announces Agreement To Acquire NxThera

Boston Scientific Announces Agreement To Acquire NxThera

Acquisition expands portfolio with minimally invasive treatment option for patients with benign prostatic hyperplasia

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ABEV, APU, EBR, FNCB, TROW Downgrades: BSX, HLF, IROQ, KR, KWR, LABL, LLY, NX Initiations: AQN Read on to get TheStreet Quant Ratings' detailed report:

Boston Scientific Announces Acquisition Of EMcision, Limited

Boston Scientific Announces Acquisition Of EMcision, Limited

Acquisition expands endoscopic portfolio to include radiofrequency devices

Boston Scientific Announces Investment And Acquisition Option Agreement With Millipede, Inc.

Boston Scientific Announces Investment And Acquisition Option Agreement With Millipede, Inc.

Millipede, Inc. is developing the IRIS Transcatheter Annuloplasty Ring System to treat severe mitral regurgitation

Quants and Charts Agree That Boston Scientific is a Buy

Quants and Charts Agree That Boston Scientific is a Buy

Boston Scientific shares are poised for more gains

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BSX, CMCM, NWY Downgrades: AMCX, AXP, CPT, IBM, PPL Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Boston Scientific Announces Positive Results From WHISPER Spinal Cord Stimulation Study

Boston Scientific Announces Positive Results From WHISPER Spinal Cord Stimulation Study

Randomized controlled trial demonstrates effectiveness of long-term treatment with sub-perception spinal cord stimulation

Boston Scientific Receives U.S. FDA Approval For Spectra WaveWriter™ Spinal Cord Stimulator System

Boston Scientific Receives U.S. FDA Approval For Spectra WaveWriter™ Spinal Cord Stimulator System

System offers non-opioid treatment option with multiple therapies for people with chronic pain

Blizzard Pounds New York, Boston as 'Bomb Cyclone' Cripples East Coast Airports

Blizzard Pounds New York, Boston as 'Bomb Cyclone' Cripples East Coast Airports

A 'Bomb Cyclone' snowstorm could dump as much as 18 inches on New York and Boston Thursday, the National Weather Service has warned, as the Atlantic coast faces yet another extreme weather battering.

TheStreet Quant Rating: A- (Buy)